Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-18-002512

Options or other derivatives

  • Chief Executive Officer acquired 437,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-01-04 Grant or award : show line 1 in the form Stock Option(right to buy) +437,500 $8.35 2028-01-04 437,500 437,500 D
Loading xslF345X03/doc4.xml…